Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
(+)-Epicatechin PK/PD in Healthy and Pre-diabetic Subjects
NCT02330276Phase 1Completed
- Sponsor
- Veterans Medical Research Foundation
- Start
- Sep 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of (+)-epicatechin in prediabetes (3 arms), sponsored by Veterans Medical Research Foundation. Primary endpoint: Change From Baseline in Circulating Urinary Concentrations of Intact Epicatechin and Epi Metabolites at 24 hours. Started Sep 2014; status: completed.
02
Drugs
(+)-epicatechin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT02330276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02330276.